Cypress Bio Revenue
Biotechnology Research • 
Portland, Oregon, United States • 1-10 Employees
Cypress Bio revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Cypress Bio
Keith Johnson
Founder
Company overview
| Headquarters | Portland, Oregon, United States |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
About Cypress Bio
Cypress Bio is an early-stage biotechnology company soon to be established in Portland, Oregon. We’re developing two complementary plant-based platforms aimed at making biopharmaceuticals more scalable, accessible, and affordable. Our first platform enables rapid, flexible protein production in plants—ideal for vaccines, biosimilars, and other biologics. Our second platform is a novel oral delivery system that converts traditionally injectable protein therapeutics into shelf-stable, lettuce-derived capsules. This innovation has the potential to transform treatment options for chronic diseases and beyond. We are currently focused on securing seed funding to establish our pilot facility, initiate production, and validate early commercial applications. Cypress Bio is rethinking how biologics are made and delivered—with plants at the center of the solution.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Cypress Bio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Cypress Bio has never raised funding before.
United Kingdom
China
CanadaFrequently asked questions
4.8
40,000 users
